OVARIAN CANCER RECURRENT

This adverse event was reported 1608 times

These drugs are most commonly taken by patients reporting OVARIAN CANCER RECURRENT:

# Drug Count
0 NIRAPARIB 498
1 OLAPARIB 356
2 BEVACIZUMAB 260
3 CARBOPLATIN 199
4 RUCAPARIB 167
5 PACLITAXEL 139
6 PACLITAXEL (AIBUMIN-BOUND) 137
7 LETROZOLE 97
8 LETROZOLE TABLETS 92
9 GEMCITABINE HYDROCHLORIDE 62
See all common drugs associated with OVARIAN CANCER RECURRENT

OVARIAN CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIRAPARIB 498 0.0225
1 OLAPARIB 356 0.0166
2 TOPOTECAN 24 0.0039
3 MIRVETUXIMAB SORAVTANSINE 4 0.0022
4 TRABECTEDIN 5 0.0021
5 BEVACIZUMAB 260 0.0021
6 LETROZOLE TABLETS 92 0.0019
7 DOXORUBICIN HYDROCHLORIDE 54 0.0016
8 LETROZOLE 97 0.0016
9 CARBOPLATIN 199 0.0015
See all drugs enriched for association with OVARIAN CANCER RECURRENT